Inflammation

Items 991-1000 of 1179

per page
Set Descending Direction
  1. EGFR, Soluble (human) (rec.)
    AG-40T-0041
    AG-40T-0041-C02525 µg
    CHF 620.00
  2. Enzolution™ MDA5 ATPase FP Assay System
    BBL-3036-FP
    BBL-3036-FP-1K1000 assays
    CHF 1'010.00
    BBL-3036-FP-10K10000 assays
    CHF 3'418.00
    BBL-3036-FP-100K10 x 10000 assaysINQ
    Enzolution™ MDA5 ATPase FP Assay System
  3. Enzolution™ MDA5 ATPase TR-FRET Assay System
    BBL-3036-TR
    BBL-3036-TR-1K1000 assays
    CHF 1'010.00
    BBL-3036-TR-10K10000 assays
    CHF 3'418.00
    BBL-3036-TR-100K10 x 10000 assaysINQ
    Enzolution™ MDA5 ATPase TR-FRET Assay System
  4. EPO (human):Fc (human) (rec.) (non-lytic)
    CHI-HF-220EPO
    CHI-HF-220EPO-C05050 µg
    CHF 430.00
  5. Erythroferrone (human) ELISA Kit
    AG-45B-0014
    AG-45B-0014-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  6. Erythroferrone (human) Matched Pair Detection Set
    AG-46B-0012
    AG-46B-0012-KI011 Set
    CHF 750.00
    Erythroferrone (human) Matched Pair Detection Set
  7. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  8. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  9. Fc (human):CD137L, Soluble (human) (rec.)
    AG-40B-0173
    AG-40B-0173-C01010 µg
    CHF 265.00
    AG-40B-0173-30103 x 10 µg
    CHF 530.00
    Fc (human):CD137L, Soluble (human) (rec.) (AG-40B-0173) binds to human CD137. Method: CD137 (human):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations of Fc (human):CD137L, Soluble (human) (AG-40B-
  10. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr

Items 991-1000 of 1179

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.